Skip to main content
OpenTrials

Clinical trial condition

Otorhinolaryngologic Diseases

Explore clinical trials studying Otorhinolaryngologic Diseases. Study availability and eligibility vary by location and protocol.

5,419 public trials 861 recruiting studies
Refine in advanced search Browse all conditions

Otorhinolaryngologic Diseases trial results

Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

NCT07195734

Conditions
Carcinoma, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +33 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sutter Medical Center Sacramento Sacramento, California, United States
View all 102 locations
View Trial Details
Recruiting

A Pivotal Study to Evaluate the Clinical Benefit, Performance and Safety of a Totally Implantable Cochlear Implant (TICI) System in Adults

NCT07287124

Conditions
Ear Diseases, Hearing Disorders, Hearing Loss, +7 more
Locations
  • Rocky Mountain Ear Center Englewood, Colorado, United States
  • University of Miami School of Medicine Miami, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
  • Michigan Ear Institute Novi, Michigan, United States
View Trial Details
Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

NCT04743141

Conditions
Acute Treatment of Migraine, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Perseverance Research Center, LLC Scottsdale, Arizona, United States
  • Physicians Research Group Tempe, Arizona, United States
  • Advanced Research Center, Inc. Anaheim, California, United States
  • ProScience Research Group Culver City, California, United States
View all 124 locations
View Trial Details
Recruiting

A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

NCT06457503

Conditions
Head and Neck Neoplasms, Nasopharyngeal Cancer Recurrent, Nasopharyngeal Diseases, +8 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Irvine Irvine, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Emory Winship Cancer Institute Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Recruiting

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

NCT06064097

Conditions
Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 85 locations
View Trial Details
Recruiting

Biospecimen Procurement for Head and Neck Disorders

NCT03429036

Conditions
Ear Diseases, Head and Neck Neoplasms, Hearing Disorder, +18 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Hospital Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • George Washington University Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins Hospital Broadway Baltimore Baltimore, Maryland, United States
View Trial Details
Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 225 locations
View Trial Details

Related conditions